Workflow
Venus cept (VERO)
icon
Search documents
Venus Concept Celebrates Successful Completion of its NEXThetics Events Across North America
Newsfilter· 2024-06-27 11:30
"NEXThetics Houston was an outstanding event, centering on the core principles of the latest technology, networking, and delivering an unparalleled experience among attendees," says Dr. Cheryl Haseeb of Pura Medical Aesthetics in Houston, Texas. "The attendees were highly engaged and eager to learn about the science behind this cutting-edge brand. They left energized and inspired to take their practice to the next level. It's truly inspiring to witness the positive impact this event has had on our professio ...
Venus Concept Celebrates Successful Completion of its NEXThetics Events Across North America
GlobeNewswire News Room· 2024-06-27 11:30
TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announces the successful completion of its NEXThetics events held across several major cities in North America. NEXThetics events bring together Venus Concept's network of aesthetic leaders and practitioners and have seen a significant increase in popularity and attendance. Since our pilot events, the Company has hosted thousands of registrants, inclu ...
Venus cept (VERO) - 2024 Q1 - Earnings Call Transcript
2024-05-15 13:55
Venus Concept Inc. (NASDAQ:VERO) Q1 2024 Earnings Conference Call May 15, 2024 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Operating Officer Domenic Della Penna - Executive Vice President and Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Jeffrey Cohen - Ladenburg Thalmann Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2024 Earnings Conference Call for Venus Concept Inc. At this time, a ...
Venus cept (VERO) - 2024 Q1 - Quarterly Report
2024-05-15 11:16
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-38238 Venus Concept Inc. (Exact Name of Registrant as Specified in its Charter) (Stat ...
Venus cept (VERO) - 2024 Q1 - Quarterly Results
2024-05-15 11:05
Exhibit 99.1 Venus Concept Announces First Quarter of Fiscal Year 2024 Financial Results TORONTO, May 15, 2024 (GLOBE NEWSWIRE) – Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2024. First Quarter 2024 Summary & Recent Progress: Management Commentary: "First quarter revenue results exceeded the expectations we outlined on our fourth quarter report," said Rajiv De Silva, Chief ...
Venus cept (VERO) - 2023 Q4 - Earnings Call Transcript
2024-04-01 14:28
Venus Concept Inc. (NASDAQ:VERO) Q4 2023 Earnings Conference Call April 1, 2024 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Operating Officer Domenic Della Penna - Executive Vice President and Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Jeffrey Cohen - Ladenburg Thalmann Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2023 Earnings Conference Call for Venus Concept Inc. At this time, ...
Venus cept (VERO) - 2023 Q4 - Annual Report
2024-04-01 11:19
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-38238 Venus Concept Inc. (Exact name of Registrant as specified in its Charter) Delaware 06-1681204 (State or other ...
Venus cept (VERO) - 2023 Q4 - Annual Results
2024-04-01 11:10
Exhibit 99.1 Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results TORONTO, April 1, 2024 (GLOBE NEWSWIRE) – Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2023. Fourth Quarter and Fiscal Year 2023 Summary & Recent Progress: Management Commentary: "Our fourth quarter revenue results reflect softer-than-expected system sales in the U.S. du ...
Venus cept (VERO) - 2023 Q3 - Earnings Call Transcript
2023-11-14 23:57
Venus Concept Inc. (NASDAQ:VERO) Q3 2023 Earnings Conference Call November 14, 2023 5:00 PM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President & Chief Operating Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Jeff Cohen - Ladenburg Thalmann Sam Eiber - BTIG Operator Please standby. Good day, ladies and gentlemen. Welcome to the Third Quarter 2023 Earnings Conference Call for Venus Concept Inc. At this time, all participants have b ...
Venus cept (VERO) - 2023 Q3 - Quarterly Report
2023-11-14 21:17
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-38238 Venus Concept Inc. (Exact Name of Registrant as Specified in its Charter) WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ( ...